20VC: Sam Altman vs Elon Musk: The $100BN Battle | The Implosion of Thinking Machines | Can VC Survive Public Market Pricing Today? | ClickHouse and Replit's New Rounds: Analysed

Summary of 20VC: Sam Altman vs Elon Musk: The $100BN Battle | The Implosion of Thinking Machines | Can VC Survive Public Market Pricing Today? | ClickHouse and Replit's New Rounds: Analysed

by Harry Stebbings

1h 18mJanuary 22, 2026

Overview of 20VC: Sam Altman vs Elon Musk — The $100BN Battle | The Implosion of Thinking Machines | Can VC Survive Public Market Pricing Today? | ClickHouse and Replit's New Rounds: Analysed

Harry Stebbings hosts Jason Lemkin and Rory O'Driscoll for a wide-ranging episode covering: the state of public markets and what that means for venture; the Sam Altman vs Elon Musk lawsuit and its implications for OpenAI; the Thinking Machines founder implosion; monetization moves at OpenAI (ads) and whether they can be a big revenue engine; and recent late-stage financings (ClickHouse, Replit, Cerebras). The discussion mixes macro market framing, legal/political drama, product/market judgments and tactical advice for founders and VCs navigating AI-led change.

Key topics covered

  • Public market multiple compression and what it means for VC returns and late-stage valuations
  • Figma’s post-IPO performance as an anchor for public-market anxiety
  • Whether venture can still win when public markets “price” assets lower
  • The OpenAI vs Elon Musk litigation: claims, likely outcomes, and strategic consequences
  • The collapse at Thinking Machines (founder departures) and seed-stage founder risk
  • OpenAI monetization — ads/Discovery as a potentially large revenue stream
  • Deep-dives on late-stage financings: ClickHouse ($15B), Replit ($9B), Cerebras ($22B)
  • Competitive investing trends among mega-funds (Sequoia, Andreessen) and LP behavior
  • Practical advice for founders: attach to AI trends or run as a scaled, self-financing business

Main takeaways and arguments

  • Public market sorting isn’t the death of tech — it rewards high-growth winners and punishes slow growers. For VC this means: be in the “hot stuff” (AI) or accept lower exits.
  • Venture’s historical role: converting huge revenue multiples into cash via IPOs/M&A. If markets shift to EPS/free-cash-flow valuation, VC returns face structural pressure unless the winners still emerge.
  • Mid-stage SaaS (e.g., $50–100M ARR growing at ~50–100%) faces fundraising friction unless they can secure AI tailwinds or change their operating model to need less external capital.
  • Practical founder playbook: (1) run your business so you can operate with less venture capital if necessary; (2) embed AI/agents to create new product-led upside; (3) accelerate revenue conversion of any AI-driven usage gains.
  • Thinking Machines’ meltdown is a classic seed/early-stage risk: founder-team fit and mission/technical credibility matter — big checks don’t eliminate core operating and cultural risks.
  • OpenAI vs Elon Musk: Elon’s suit claims he was misled (donation framed as charity) and seeks a massive dilution or damages tied to current OpenAI value. Legally hard to prove but discovery/depositions will be reputationally damaging and could complicate financings; Elon has asymmetric upside (can litigate for psychic and strategic impact).
  • Ads in LLMs/Chat interfaces are likely inevitable and could be valuable for discovery — potentially a meaningful revenue stream for OpenAI if executed well (auction model, relevance). Could scale to large numbers rapidly.
  • ClickHouse and Replit are examples of older products that found AI tailwinds and rapidly re-rated; late-stage investors are paying for growth persistence and category leadership — high risk if growth decelerates.

Notable quotes / soundbites

  • “If Figma isn’t good enough, what hope is there for the rest of us in software?”
  • “Venture is nothing if not a trend business.”
  • “Our job is to convert very high revenue multiples into cash almost unnaturally.”
  • “Elon’s in an asymmetric win-win situation, and OpenAI is not.”
  • “Ads are inevitable — America wants free stuff, and the way to fund it is advertising.”

Company / story breakdowns

  • Figma: Still large and growing (cited ~30%+), trading at lower forward-sales multiples — used as a benchmark for public market recalibration.
  • OpenAI / Sam Altman vs Elon Musk: Elon alleges fraud/misrepresentation over early donations when OpenAI was a nonprofit; seeks outsized damages (dilution/shares tied to today's valuation). Trial likely to be messy; outcome uncertain — significant reputational and financing noise regardless.
  • Thinking Machines: Founder departures highlight seed-stage founder-fit risk; large capital doesn’t immunize teams from breakups.
  • ClickHouse: Open-source OLAP turned hosted SaaS — fits AI/analytics tailwinds; the late-stage $15B price reflects underwriting of sustained hyper-growth and category leadership.
  • Replit: Product matured significantly; agent-based dev workflow is materially better, supporting the higher valuation if revenue acceleration persists.
  • Cerebras (Cerebris in transcript): large AI-infrastructure plays are capturing investor enthusiasm — valuations assume continued AI compute demand.

Implications for founders and VCs — actionable recommendations

For founders:

  • If you’re a mid-stage SaaS company, prioritize attaching to AI (agents or substantive AI features) or restructure to reduce capital dependency.
  • Focus on converting usage and developer adoption into sustainable revenue (RevenueCat-style playbooks).
  • Product-first: ship agents and meaningful AI features — being “AI-adjacent” is insufficient.

For VCs / investors:

  • Re-evaluate late-stage underwriting assumptions: you’re paying for growth persistence and category dominance.
  • Expect to pay for access to mega-rounds; many large LPs will accept small ownership to get exposure to perceived category winners.
  • Treat litigation/PR risk (e.g., OpenAI’s trial) as an asterisk when pricing rounds — assign probabilities for dilution events, but don’t assume binary outcomes.

For operators:

  • Prepare for LLM ad ecosystems: think about discovery signals, SEO/AEO, and how your product can surface in LLM-generated recommendations.
  • Invest in data instrumentation and OLAP/analytics infrastructure — systems like ClickHouse can be strategic.

What to watch next (predictions / signals)

  • Outcome and discovery from the OpenAI vs Musk litigation: reputation & fundraising impact over the next 12–36 months.
  • Speed and effectiveness of LLM ad monetization (initial revenue trajectory; CPMs; AUCTION workings).
  • Revenue growth persistence at ClickHouse and Replit — whether growth continues to justify late-stage multiples.
  • Degree to which mid-stage SaaS companies successfully attach to AI (product-led growth) versus carving a hard path as profitable, self-sustaining businesses.

Sponsors & brief practical plugs (from episode)

  • Founder advice: pick a .tech domain for early-stage tech startups.
  • Checkout.com: payments for digital commerce and agentic commerce integrations.
  • Invisible: operationalizing AI models into real business outcomes (data wrangling + model adaptation).

This episode is a dense mix of tech market framing, legal drama and tactical advice — essential listening for founders and investors deciding how to position for AI’s next phase.